J&J expects double-digit 2023 profit growth after Kenvue spinoff

United States News News

J&J expects double-digit 2023 profit growth after Kenvue spinoff
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

Johnson & Johnson on Wednesday forecast double-digit profit growth for 2023 after spinning off consumer health company Kenvue , unveiling the first outlook for its standalone drugs and medical device businesses.

J&J finalized the biggest shake-up in its 137-year history earlier this month through an exchange of its shares with Kenvue's, leaving the pharmaceutical giant with a reduced 9.5% stake in its former unit.

Kenvue debuted on the New York Stock Exchange in May and has a market capitalization of nearly $79 billion, with J&J generating $13.2 billion in cash proceeds as a result of its debt offering and initial public offering. "The main driver for this transaction always has been the strategic rationale of having both companies be more agile, flexible and focused for success in their respective industries," J&J CFO Joseph Wolk said in a pre-recorded investor call.

J&J expects 2023 adjusted reported earnings per share of $10 to $10.10, which is 12.5% higher at the midpoint compared with 2022. The company also said it would present its consumer health business as discontinued operations and record a gain of $20 billion in the third quarter as a result of the spinoff.this year, saying it expected demand for joint replacement and other surgeries to rebound with COVID-19 and inflation tempering.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

J&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff By ReutersJ&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff By ReutersJ&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff
Read more »

J&J revises 2023 sales, profit outlook lower after Kenvue separation, will maintain dividendJ&J revises 2023 sales, profit outlook lower after Kenvue separation, will maintain dividendJohnson & Johnson updated on Wednesday its 2023 financial guidance in the wake of the Kenvue Inc. separation that was completed last week. The drug maker now...
Read more »

The Killer (2023) (2023) | ScreenRantThe Killer (2023) (2023) | ScreenRantBased on the graphic novel by Alexis Nolent, The Killer is a Netflix film directed by David Fincher. Michael Fassbender stars as the titular character. This hitman experiences a near-miss on a mission and now must wrestle with his conscience and his employers as he begins to fight against his ways as an assassin.
Read more »

A Multicultural Legend Will Be Honored at the MTV VMAs 2023 - 2023 MTV Video Music AwardsA Multicultural Legend Will Be Honored at the MTV VMAs 2023 - 2023 MTV Video Music AwardsShakira has been dazzling audiences and breaking boundaries for decades, and she'll take the stage as the Video Vanguard honoree at this year's MTV VMAs, live on September 12 at 8/7c.
Read more »



Render Time: 2025-02-23 03:36:24